Birchview Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $830K | Sell |
30,000
-6
| -0% | -$166 | 0.82% | 28 |
|
2025
Q1 | $666K | Buy |
30,006
+6
| +0% | +$133 | 0.58% | 28 |
|
2024
Q4 | $593K | Hold |
30,000
| – | – | 0.48% | 28 |
|
2024
Q3 | $750K | Hold |
30,000
| – | – | 0.65% | 25 |
|
2024
Q2 | $560K | Hold |
30,000
| – | – | 0.52% | 28 |
|
2024
Q1 | $592K | Hold |
30,000
| – | – | 0.48% | 33 |
|
2023
Q4 | $526K | Hold |
30,000
| – | – | 0.41% | 33 |
|
2023
Q3 | $521K | Hold |
30,000
| – | – | 0.44% | 34 |
|
2023
Q2 | $422K | Hold |
30,000
| – | – | 0.32% | 37 |
|
2023
Q1 | $323K | Hold |
30,000
| – | – | 0.25% | 41 |
|
2022
Q4 | $449K | Hold |
30,000
| – | – | 0.32% | 36 |
|
2022
Q3 | $385K | Hold |
30,000
| – | – | 0.27% | 44 |
|
2022
Q2 | $291K | Hold |
30,000
| – | – | 0.21% | 48 |
|
2022
Q1 | $298K | Hold |
30,000
| – | – | 0.21% | 52 |
|
2021
Q4 | $353K | Hold |
30,000
| – | – | 0.23% | 52 |
|
2021
Q3 | $342K | Buy |
30,000
+10,000
| +50% | +$114K | 0.23% | 51 |
|
2021
Q2 | $279K | Buy |
+20,000
| New | +$279K | 0.17% | 56 |
|